All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


← First12345...711Next →

hiv & aids news selected from other sources

  • New and experimental HIV treatments
    European Commission approves Rezolsta ® , a new once - daily , fixed - dose HIV therapy combining darunavir and cobicistat
    Janssen | 10 hours ago

    Janssen-Cilag International NV (Janssen) today announced that the European Commission (EC) has approved the use of REZOLSTA ® (darunavir/cobicistat) in combination with other antiretroviral (ARV) medicinal products for the treatment of human immunodeficiency virus - 1 (HIV - 1) infection in adults aged 18 years or older. "REZOLSTA ® eliminates the need to take a boosting agent in a separate tablet with once - daily darunavir, reducing the pill burden for patients," said Christiane Moecklinghoff, M.D Ph.D, Medical Director, Virology, Janssen EMEA.

  • Injecting drug use
    Why the UK’s drug strategy should remain a Home Office responsibility
    The Guardian | 12 hours ago

    Handing the reins to the Department of Health might seem a liberal-minded approach, but it could mean less is spent on treatment. Drug use simply doesn’t cause as much ill-health as other risky behaviours, so isn't prioritised by health officials. But it is seen as a major cause of crime.

  • Testing policies and guidelines
    Sexual health charity launches webtool to increase HIV testing in primary care
    MEDFASH press release | 13 hours ago

    With a quarter of the estimated 108,000 people living with HIV i still going undiagnosed, MEDFASH has developed HIV Testing in Practice (HIV TIPs), an online educational tool, to help increase rates of HIV diagnosis in primary care. Launched in National HIV Testing Week, the interactive webtool will enable GPs, practice nurses and their teams to raise their knowledge of HIV and enhance their confidence in offering HIV testing.

  • Starting treatment
    START Study Could Change How We Look at HIV Treatment, and HIV Itself
    The Body | 16 hours ago

    Have you heard of the START (Strategic Timing of Antiretroviral Treatment) study? In my opinion, it is probably the most important study currently running. It generates strong views, both for and against initiating antiretroviral therapy early, but the results are likely to be surprising.

  • HIV prevention policy
    Rumours of the demise of HIV have been greatly exaggerated
    The Conversation | 17 hours ago

    Two years ago, the “beginning of the end” of AIDS was announced. It included the promise of reducing HIV transmission by reducing the amount of infectious virus in the population. But disease control will fail unless we understand and plan for its translation within complex and adaptive systems. People take up technologies and use them in unanticipated ways. Cultures develop resistance in the same way that bacteria do. We will only ever approach the beginning of the end of AIDS if and when we bear these things in mind.

  • Young people
    AIDS is No. 1 Killer of African Teenagers
    Inter Press Service | 17 hours ago

    HIV among teenagers is devastating families in Nigeria and elsewhere in Africa, where AIDS has become the leading cause of death among adolescents. One reason for this shocking teen death toll is the low number of adolescents on antiretroviral treatment (ART).

  • Injecting drug use
    DrugScope responds to Iain Duncan Smith's comments about methadone
    DrugScope | 17 hours ago

    A response to the Secretary of State for Work and Pensions' article "Now fight the methadone industry that keeps addicts hooked".

  • The search for a cure
    Narrow Time Window Exists to Start HIV Therapy, Study Shows
    Infection Control Today | 18 hours ago

    HIV-1-infected U.S. military members and beneficiaries treated with antiretroviral therapy (ART) soon after infection were half as likely to develop AIDS and were more likely to reconstitute their immune-fighting CD4+ T-cells to normal levels, researchers reported Nov. 24 in JAMA Internal Medicine.

  • Injecting drug use
    Why heroin has made a comeback in America
    The Economist | 24 November 2014

    Last year nearly 700,000 Americans took the drug, twice as many as a decade ago. It is now more popular than crack, by some measures. What explains heroin’s return?

  • Epidemiology and behaviour
    Invisible sexuality: older adults missing in sexual health research
    The Conversation | 24 November 2014

    The Australian Study of Health and Relationships (ASHR), the latest findings of which were released recently, has much to commend it. Like its counterpart, the British National Survey of Sexual Attitudes and Lifestyles (NATSAL), it provides an illustration of sexual practices of today’s adults. Both studies leave out a significant proportion of the population – older adults.

← First12345...972Next →

Hepatitis C news

WHO recommends global use of newest hepatitis C drugs, urges price reductions.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Treatment as prevention

No-one with an undetectable viral load, gay or heterosexual, transmits HIV in two years of PARTNER study.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.